Assessing adherence to evidence-based guidelines of care for acne vulgaris

Dunaway, Spencer; Fleischer, Alan B.

doi:10.1080/09546634.2020.1729950

Cited by 6 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The NAMCS is developed from an independent annual survey of office‐based visits sampling US physician practices and is conducted by the National Center for Health Statistics (NCHS) 22 . NAMCS data collection methods have been validated and extensively described elsewhere 22‐27 .…”

Section: Methodsmentioning

confidence: 99%

“…22 NAMCS data collection methods have been validated and extensively described elsewhere. [22][23][24][25][26][27] Sampled physicians in the NAMCS are selected from a pool of non-federal, office-based physicians and surgeons, in solo or group practice, who are registered with the American Medical Association and the American Osteopathic Association.…”

Section: Materials S and Me Thodsmentioning

confidence: 99%

“…The NAMCS is developed from an independent annual survey of office-based visits sampling US physician practices and is conducted by the National Center for Health Statistics (NCHS). 22 NAMCS data collection methods have been validated and extensively described elsewhere. [22][23][24][25][26][27] Sampled physicians in the NAMCS are selected from a pool of non-federal, office-based physicians and surgeons, in solo or group practice, who are registered with the American Medical Association and the American Osteopathic Association.…”

Section: Materials S and Me Thodsmentioning

confidence: 99%

See 2 more Smart Citations

Trends in utilization of non‐first‐line topical acne medications among children, adolescents, and adults in the United States, 2012‐2016

Afarideh

Baisi

Davis

et al. 2021

Pediatric Dermatology

View full text Add to dashboard Cite

Topical benzoyl peroxide (BP), retinoids, or a combination is recommended by the American Academy of Dermatology (AAD) as the first-line topical agents for the management of mild-tomoderate acne, with the addition of topical or oral antibiotics as additional first-line therapeutic options. 1 Additional medications are recommended in the AAD acne guidelines as non-first-line topical agents, including azelaic acid, salicylic acid, glycolic acid, sulfur, zinc, and resorcinol, all of which have varying strengths of recommendation. 1 Between 1996 and 2005, first-line agents BP, topical clindamycin, and tretinoin were the most commonly

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Materials S and Me Thodsmentioning

confidence: 99%

Section: Materials S and Me Thodsmentioning

confidence: 99%

See 1 more Smart Citation

Trends in utilization of non‐first‐line topical acne medications among children, adolescents, and adults in the United States, 2012‐2016

Afarideh

Baisi

Davis

et al. 2021

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

“…Managing acne scars is a challenge, 7‐10 and therapies are divided into nonsurgical and surgical. The former includes anti‐acne agents, 11,12 chemical peels, 13 microneedling, 14‐17 and ablative 18 and nonablative fractional 19‐22 and nonfractional 23 lasers, as well as autologous growth factors 24‐27 .…”

Section: Introductionmentioning

confidence: 99%

Prospective and randomized comparative study of calcium hydroxylapatite vs calcium hydroxylapatite plus HIFU in treatment of moderate‐to‐severe acne scars

Araco

Araco²

2020

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Acne scars are the most common sequelae of the severe inflammatory process of acne. They affect almost 95 percent of patients with acne vulgaris, which is prevalent in more than 90 percent of adolescents. 1,2 Scars are characterized by a loss or damage of tissue, vary in morphological characteristics such as shape, size, and depth, 3 and are graded as various types such as rolling, boxcar, and ice pick. Furthermore, they can be erythematous at the early stage, or may get purplish or pigmented as they develop. 4,5 In most patients, acne scars are mixed types and distributed around the face. A standard tool for assessing atrophic scars is the four-grade Goodman and Baron classification. 6 Managing acne scars is a challenge, 7-10 and therapies are divided into nonsurgical and surgical. The former includes anti-acne agents, 11,12 chemical peels, 13 microneedling, 14-17 and ablative 18 and nonablative fractional 19-22 and nonfractional 23 lasers, as well as autologous growth factors. 24-27 The latter include subcision, 28-30 autologous cell regeneration, 31 and autologous adipose-derived stem cells. 32

show abstract